Growth Metrics

Biogen (BIIB) Non-Current Assets (2016 - 2026)

Biogen has reported Non-Current Assets over the past 18 years, most recently at $20.3 billion for Q1 2026.

  • For Q1 2026, Non-Current Assets fell 0.56% year-over-year to $20.3 billion; the TTM value through Mar 2026 reached $81.4 billion, down 0.96%, while the annual FY2025 figure was $20.5 billion, 0.62% down from the prior year.
  • Non-Current Assets for Q1 2026 was $20.3 billion at Biogen, down from $20.5 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $21.5 billion in Q3 2024 and troughed at $14.7 billion in Q2 2023.
  • A 5-year average of $18.4 billion and a median of $19.8 billion in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: dropped 11.26% in 2022 and later skyrocketed 35.38% in 2023.
  • Year by year, Non-Current Assets stood at $14.8 billion in 2022, then skyrocketed by 35.38% to $20.0 billion in 2023, then grew by 3.04% to $20.6 billion in 2024, then fell by 0.62% to $20.5 billion in 2025, then fell by 0.84% to $20.3 billion in 2026.
  • Business Quant data shows Non-Current Assets for BIIB at $20.3 billion in Q1 2026, $20.5 billion in Q4 2025, and $20.3 billion in Q3 2025.